Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Androgens and anabolic steroids
Acolbifene/prasterone
Другие языки:

    Acolbifene/prasterone

    Подписчиков: 0, рейтинг: 0
    Acolbifene/prasterone
    Combination of
    Acolbifene Selective estrogen receptor modulator
    Prasterone Androgen
    Clinical data
    Trade names Femivia (tentative)
    Other names Prasterone/acolbifene; Acolbifene/DHEA; DHEA/Acolbifene
    Routes of
    administration    		 By mouth

    Acolbifene/prasterone (tentative brand name Femivia) is a combination formulation of acolbifene, a selective estrogen receptor modulator, and prasterone (dehydroepiandrosterone; DHEA), an androgen, estrogen, and neurosteroid, which is under development by Endoceutics for the treatment of vasomotor symptoms (hot flashes) in postmenopausal women. It is intended for use by mouth. As of December 2017, it is in phase III clinical trials for this indication.

    See also

    External links




    Новое сообщение